Jianjiong Gao

Memorial Sloan Kettering Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

80h-index104.1kcitations337works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(123), Lung Cancer Treatments and Mutations(47), Bioinformatics and Genomic Networks(40), Radiomics and Machine Learning in Medical Imaging(29), RNA modifications and cancer(27)

Publications278 total

2MO Integrated histopathologic modeling of detailed tumor subtypes and actionable biomarkers
ESMO Real World Data and Digital Oncology·2025Open Access
Identifying Potential Mechanisms Whereby Knocking Down YAP in Adipocytes Improves Glucose Metabolism
Canadian Journal of Diabetes·2025
Tamoxifen induces PI3K activation in uterine cancer
Nature Genetics·2025· 5 citedOpen Access
Integrated histopathologic modeling of detailed tumor subtypes and actionable biomarkers
2025Open Access
Abstract P1-03-16: Multimodal analyses of clinical, radiology, pathology and genomic information for enhanced prediction of response to neoadjuvant therapy in breast cancer
Clinical Cancer Research·2025· 1 cited
Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers
npj Precision Oncology·2025· 3 citedOpen Access
Abstract 7109: Understanding race-specific differences in the predictive performance of computational outcome models for breast cancer
Cancer Research·2025
Abstract 1117: cBioPortal for cancer genomics
Cancer Research·2025
Abstract 2464: Inferring genomic properties from H&E whole-slide images of >60,000 solid tumors
Cancer Research·2025
Abstract 5043: reVUE: repository for variants with unexpected effects
Cancer Research·2025
Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers
2024Open Access
Automated real-world data integration improves cancer outcome prediction
Nature·2024· 114 citedOpen Access
Abstract 1249: cBioPortal for Cancer Genomics
Cancer Research·2024· 1 cited
Table S1 from Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
2024Open Access
Figure S1 from Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
2024Open Access
Supplementary Note 1 and Note 2 from Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
2024Open Access
Figure S1 from Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
2024Open Access
Table S6 from Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
2024Open Access
Figure S2 from Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
2024Open Access
Table S2 from Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
2024Open Access
page 1 of 14Next →

Frequent Co-authors

Nikolaus Schultz(29), Ritika Kundra(16), David B. Solit(16), Ahmet Zehir(14), Michael F. Berger(14), Debyani Chakravarty(13), Barry S. Taylor(13), Marc Ladanyi(13), David M. Hyman(11), Benjamin Groß(9), Hongxin Zhang(8), Wassim Abida(7), Matthew T. Chang(7), Ino de Bruijn(7), Ethan Cerami(6), S. Onur Sumer(6), Chris Sander(6), Howard I. Scher(6), Alexander Penson(6), Gregory J. Riely(6)